Author Question: A patient will begin treatment with posaconazole Noxafil to treat oropharyngeal candidiasis that has ... (Read 26 times)

erika · **on:** Jul 23, 2018

A patient will begin treatment with posaconazole Noxafil to treat oropharyngeal candidiasis that has not responded to fluconazole. The provider has ordered 200 mg three times daily. Which action by the nurse is correct?

a. Administer the drug as ordered.
b. Contact the provider to discuss decreasing the dose to twice daily.
c. Discuss a 400-mg twice daily drug regi-men with the provider.
d. Suggest to the provider that this dose may be too high for this indication.

Question 2

A child has ringworm of the scalp. A culture of the lesion reveals a dermatophytic infection. The nurse teaching the child's parents about how to treat this infection will include which statement?

a. Adverse effects of the medication in-clude itching, burning, and erythema.
b. Apply the topical medication daily until at least 1 week after the rash is gone.
c. Your child will need to take this oral medication for 6 to 8 weeks.
d. You will use an antifungal shampoo to treat this infection.

itsakadoozi · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

C
When given for treatment of oropharyngeal candidiasis that is refractory to treatment with itra-conazole or fluconazole, the dose is 400 mg twice daily. A dosage regimen of 200 mg three times daily is used for prophylaxis of invasive fungal infections and decreasing this to twice daily is not correct.

Answer to Question 2

C
Tinea capitis is difficult to treat with topical medications; oral griseofulvin, taken for 6 to 8 weeks, is standard therapy. Itching, burning, and erythema are side effects of topical agents. Pa-tients treating tinea corporis, tinea cruris, or tinea pedis are taught to apply medication until 7 days after the rash disappears. Antifungal shampoos are not effective for treating tinea capitis.